The Day In Parliament for 18 August 2016 - morning edition

Health Committee receives a petition regarding melanoma treatment drugs, and hears concerns about Pharmac's model for approving the funding of such medicines; The committee also hears submissions on a notice of motion regarding the reclassification of the recreational drug N-bomb, including from Ministry of Health officials as well as the New Zealand Drug Foundation - who's executive director Ross Bell points to issues with the proposed changes; Government heralds its plans to sign the Paris Agreement on Climate Change, though not without facing criticism from the opposition; New Zealand First leader Winston Peters uses the General Debate to raise concerns about immigration.